JP2010502210A5 - - Google Patents

Download PDF

Info

Publication number
JP2010502210A5
JP2010502210A5 JP2009527228A JP2009527228A JP2010502210A5 JP 2010502210 A5 JP2010502210 A5 JP 2010502210A5 JP 2009527228 A JP2009527228 A JP 2009527228A JP 2009527228 A JP2009527228 A JP 2009527228A JP 2010502210 A5 JP2010502210 A5 JP 2010502210A5
Authority
JP
Japan
Prior art keywords
ovol1
stem cells
cancer stem
expression
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009527228A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010502210A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2007/003648 external-priority patent/WO2008029290A2/en
Publication of JP2010502210A publication Critical patent/JP2010502210A/ja
Publication of JP2010502210A5 publication Critical patent/JP2010502210A5/ja
Pending legal-status Critical Current

Links

JP2009527228A 2006-09-07 2007-09-07 遺伝子マーカーを使用する癌幹細胞の同定 Pending JP2010502210A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06018771 2006-09-07
PCT/IB2007/003648 WO2008029290A2 (en) 2006-09-07 2007-09-07 Identification of cancer stem cells using genetic markers

Publications (2)

Publication Number Publication Date
JP2010502210A JP2010502210A (ja) 2010-01-28
JP2010502210A5 true JP2010502210A5 (enExample) 2010-10-28

Family

ID=39157635

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009527228A Pending JP2010502210A (ja) 2006-09-07 2007-09-07 遺伝子マーカーを使用する癌幹細胞の同定

Country Status (5)

Country Link
US (1) US20100034736A1 (enExample)
EP (1) EP2059613A2 (enExample)
JP (1) JP2010502210A (enExample)
CA (1) CA2662843A1 (enExample)
WO (1) WO2008029290A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100196905A1 (en) * 2009-01-30 2010-08-05 Kci Licensing, Inc. Adult Stem Cell Assays
KR101231235B1 (ko) 2010-04-21 2013-02-08 고려대학교 산학협력단 전립선암 줄기세포 선별용 단백질성 마커
KR101240199B1 (ko) 2010-04-26 2013-03-06 고려대학교 산학협력단 대장암 줄기세포 선별용 단백질성 마커
HRP20200961T1 (hr) * 2011-07-21 2020-10-02 Menarini Silicon Biosystems S.P.A. Test za hvatanje i detektiranje cirkulirajućih stanica multiplog mijeloma iz krvi
CN103151461A (zh) 2013-02-27 2013-06-12 京东方科技集团股份有限公司 一种有机薄膜晶体管及其制备方法和制备装置
ES2651522T3 (es) * 2013-12-16 2018-01-26 Humanitas Mirasole S.P.A. Altos niveles de FT de TEM para el diagnóstico del cáncer, en particular de cáncer colorrectal (CCR) y de páncreas (CP)
KR101805181B1 (ko) 2016-09-02 2017-12-07 충북대학교 산학협력단 인산화된 slug 단백질의 유사분열 세포에 대한 신규한 바이오 마커로서의 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2195751B1 (es) * 2001-11-27 2005-04-01 Universidad De Salamanca (Otri) Mamiferos no humanos transgenicos como modelos para patologias humanas con origen en celulas stem.
CA2469204A1 (en) * 2001-12-07 2003-06-19 Regents Of The University Of Michigan Prospective identification and characterization of breast cancer stem cells
WO2003058201A2 (en) * 2001-12-31 2003-07-17 Quark Biotech, Inc. Methods for identifying marker genes for cancer
AU2003207708A1 (en) * 2002-02-20 2003-09-09 Sirna Therapeutics, Inc. Rna interference mediated inhibition of map kinase genes
EP1530418A4 (en) * 2002-05-31 2005-10-12 Univ Leland Stanford Junior METHOD FOR IDENTIFYING AND INSULATING STEM CELLS AND CANCER STAMPS
US20040170605A1 (en) * 2003-02-27 2004-09-02 Garcia Isidro Sanchez Use of the slug gene as a genetic marker in functions mediated by SCF (stem cell factor) and applications
US7927795B2 (en) * 2003-06-09 2011-04-19 Board Of Trustees Of The University Of Arkansas Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium
KR20060031809A (ko) * 2003-06-09 2006-04-13 더 리젠츠 오브 더 유니버시티 오브 미시간 암 치료 및 진단용 조성물 및 방법
JP2005000056A (ja) * 2003-06-11 2005-01-06 Sumitomo Pharmaceut Co Ltd ホルモン依存性癌疾患マーカー及びその利用
WO2006002378A2 (en) * 2004-06-23 2006-01-05 Avalon Pharmaceuticals Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods
ES2301268B1 (es) * 2004-10-25 2009-05-01 Centro De Investigacion Biomolecular Aplicada Salamanca, S.L. Empleo del gen slug, o de sus productos de replicacion, transcripcion o expresion, en la identificacion, diagnostico, prevencion o tratamiento de la diseminacion del cancer y/o desarrollo de metastasis.
CA2629330C (en) * 2004-11-12 2018-05-22 Cambridge University Technical Services Ltd. Methods and means related to cancer stem cells
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer

Similar Documents

Publication Publication Date Title
Hu et al. Circular RNA sequencing identifies CircASAP1 as a key regulator in hepatocellular carcinoma metastasis
Peng et al. Identification of miRs-143 and-145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT
Wang et al. c‐Myc‐mediated epigenetic silencing of MicroRNA‐101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma
Jiang et al. Current prevalence status of gastric cancer and recent studies on the roles of circular RNAs and methods used to investigate circular RNAs
Ji et al. Identification of microRNAs specific for epithelial cell adhesion molecule–positive tumor cells in hepatocellular carcinoma
Libório-Kimura et al. miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer
JP2010502210A5 (enExample)
Malz et al. Overexpression of far upstream element (FUSE) binding protein (FBP)‐interacting repressor (FIR) supports growth of hepatocellular carcinoma
KR20190036553A (ko) 전이성 암의 치료 및 전이성 질환에 대한 모델 시스템
Zhang et al. piR-001773 and piR-017184 promote prostate cancer progression by interacting with PCDH9
Lin et al. CircRNA CircRIMS acts as a MicroRNA sponge to promote gastric cancer metastasis
Pan et al. ERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC)
Liu et al. The expression pattern of microRNAs and the associated pathways involved in the development of porcine placental folds that contribute to the expansion of the exchange surface area
Han et al. Whole transcriptome analysis of mesenchyme tissue in sika deer antler revealed the CeRNAs regulatory network associated with antler development
Wei et al. CircRFWD3 promotes HNSCC metastasis by modulating miR-27a/b/PPARγ signaling
Makino et al. STAT3 is activated by CTGF-mediated tumor-stroma cross talk to promote HCC progression
WO2020093574A1 (zh) 一种肿瘤相关序列、长链非编码rna及其应用
JP6202659B2 (ja) 癌組織の不均一性マーカー及びその使用
Zhang et al. SOX2 inhibits LLGL2 polarity protein in esophageal squamous cell carcinoma via miRNA-142-3p
JP2014207883A (ja) がん幹細胞及びその用途
Liu et al. Hsa_circ_0001944 enhanced GSPT1 expression via sponging miR‐498 to promote proliferation and invasion of gastric cancer
He et al. Mtu1 defects are correlated with reduced osteogenic differentiation
US10221460B2 (en) Methods and kits for the prognosis and treatment of prostate cancer
CN102433388B (zh) 一种肝癌早期诊断试剂盒
CN114214430A (zh) Nkg2a在检测小鼠人源肿瘤模型中人nk细胞中的应用